Product Ref: MBPRO10 Category: P
Royal Mail Tracked 24 (Signed For)
Royal Mail Special Delivery Guaranteed by 1pm
Category | POM-V |
Temperature | Refrigerated |
MA/VM/EU No: | 04491/5047 |
Species |
|
VMD Link | https://www.vmd.defra.gov.uk/ProductInformationDatabase/product/A006565 |
NOAH Link | |
Dosage | Amounts to be administered and administration route For intramuscular use. For the administration of the vaccine, use sterile and antiseptic-free and/or disinfectant-free material. Shake the vaccine gently before use. Administer one dose (1 ml), by intramuscular injection, preferably in the neck region, according to the following schedule: Primary vaccination course with ProteqFlu-Te: First injection from 5-6 months of age, second injection 4-6 weeks later. Revaccination: 5 months after primary vaccination course with ProteqFlu-Te. Followed by: - against tetanus: injection of 1 dose at an interval of maximum 2 years with ProteqFlu-Te. - against equine influenza: injection of 1 dose every year, alternatively with ProteqFlu or ProteqFlu-Te, respecting an interval of maximum 2 years for the tetanus component. In case of increased infection risk or insufficient colostrum intake, an additional initial injection of ProteqFlu-Te can be given at the age of 4 months followed by the full vaccination programme (primary vaccination course at 5-6 months of age and 4-6 weeks later followed by revaccination). Overdose Following the administration of overdoses of vaccine, no side-effects other than those described under Adverse reactions have been observed. |
Withdrawals |